Fate Therapeutics Statistics
Total Valuation
FATE has a market cap or net worth of $137.27 million. The enterprise value is $1.09 million.
Important Dates
The next estimated earnings date is Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FATE has 115.35 million shares outstanding. The number of shares has increased by 8.77% in one year.
| Current Share Class | 115.35M |
| Shares Outstanding | 115.35M |
| Shares Change (YoY) | +8.77% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 1.46% |
| Owned by Institutions (%) | 63.29% |
| Float | 100.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.75 |
| Forward PS | 36.43 |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.87, with a Debt / Equity ratio of 0.34.
| Current Ratio | 7.87 |
| Quick Ratio | 7.74 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.35% and return on invested capital (ROIC) is -25.82%.
| Return on Equity (ROE) | -52.35% |
| Return on Assets (ROA) | -23.85% |
| Return on Invested Capital (ROIC) | -25.82% |
| Return on Capital Employed (ROCE) | -50.70% |
| Revenue Per Employee | $39,431 |
| Profits Per Employee | -$862,398 |
| Employee Count | 181 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.85% in the last 52 weeks. The beta is 2.23, so FATE's price volatility has been higher than the market average.
| Beta (5Y) | 2.23 |
| 52-Week Price Change | -9.85% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 1.14 |
| Relative Strength Index (RSI) | 62.34 |
| Average Volume (20 Days) | 1,751,501 |
Short Selling Information
The latest short interest is 10.07 million, so 8.73% of the outstanding shares have been sold short.
| Short Interest | 10.07M |
| Short Previous Month | 8.82M |
| Short % of Shares Out | 8.73% |
| Short % of Float | 9.99% |
| Short Ratio (days to cover) | 7.40 |
Income Statement
In the last 12 months, FATE had revenue of $7.14 million and -$156.09 million in losses. Loss per share was -$1.32.
| Revenue | 7.14M |
| Gross Profit | -92.41M |
| Operating Income | -159.99M |
| Pretax Income | -156.09M |
| Net Income | -156.09M |
| EBITDA | -145.34M |
| EBIT | -159.99M |
| Loss Per Share | -$1.32 |
Full Income StatementBalance Sheet
The company has $215.42 million in cash and $79.25 million in debt, with a net cash position of $136.18 million or $1.18 per share.
| Cash & Cash Equivalents | 215.42M |
| Total Debt | 79.25M |
| Net Cash | 136.18M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 234.07M |
| Book Value Per Share | 2.03 |
| Working Capital | 193.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$110.57 million and capital expenditures -$4.86 million, giving a free cash flow of -$115.43 million.
| Operating Cash Flow | -110.57M |
| Capital Expenditures | -4.86M |
| Free Cash Flow | -115.43M |
| FCF Per Share | -$1.00 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,241.75% |
| Pretax Margin | -2,187.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FATE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.77% |
| Shareholder Yield | -8.77% |
| Earnings Yield | -113.71% |
| FCF Yield | -84.09% |
Analyst Forecast
The average price target for FATE is $3.92, which is 229.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.92 |
| Price Target Difference | 229.41% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 54.64% |
| EPS Growth Forecast (5Y) | -15.86% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FATE has an Altman Z-Score of -6.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.02 |
| Piotroski F-Score | 1 |
